Tetracycline labeling of the femoral head following acute intracapsular fracture of the femoral neck

K. P. Speer, Leigh Quarles, J. M. Harrelson, J. A. Nunley

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The purpose of this study was to assess the utility of tetracycline hydrochloride (HCl) labeling of the femoral head following acute intracapsular fracture of the femoral neck to indirectly assess femoral head viability and vascularity. A standard labeling (1.5-3.0 g) and fixative protocol (70% ethanol) was used. The initial tetracycline dose was given in the emergency room. The time from last dose to bone sampling in the operating room ranged from six to 36 hours (average, 21.2 hours). There was no evidence of tetracycline deposition at the bone-osteoid interface in any of the femoral head specimens or the ipsilateral extracapsular greater trochanter control specimens. Sources of labeling failure are multifactorial: problems with label delivery to the patient, in vivo deposition of the label, and the fixation protocol.

Original languageEnglish (US)
Pages (from-to)224-227
Number of pages4
JournalClinical Orthopaedics and Related Research
Issue number267
StatePublished - 1991
Externally publishedYes

Fingerprint

Femoral Neck Fractures
Thigh
Tetracycline
Bone and Bones
Fixatives
Operating Rooms
Femur
Hospital Emergency Service
Ethanol

All Science Journal Classification (ASJC) codes

  • Orthopedics and Sports Medicine
  • Surgery

Cite this

Tetracycline labeling of the femoral head following acute intracapsular fracture of the femoral neck. / Speer, K. P.; Quarles, Leigh; Harrelson, J. M.; Nunley, J. A.

In: Clinical Orthopaedics and Related Research, No. 267, 1991, p. 224-227.

Research output: Contribution to journalArticle

@article{712ccc634b8546ea937b79fad6c45657,
title = "Tetracycline labeling of the femoral head following acute intracapsular fracture of the femoral neck",
abstract = "The purpose of this study was to assess the utility of tetracycline hydrochloride (HCl) labeling of the femoral head following acute intracapsular fracture of the femoral neck to indirectly assess femoral head viability and vascularity. A standard labeling (1.5-3.0 g) and fixative protocol (70{\%} ethanol) was used. The initial tetracycline dose was given in the emergency room. The time from last dose to bone sampling in the operating room ranged from six to 36 hours (average, 21.2 hours). There was no evidence of tetracycline deposition at the bone-osteoid interface in any of the femoral head specimens or the ipsilateral extracapsular greater trochanter control specimens. Sources of labeling failure are multifactorial: problems with label delivery to the patient, in vivo deposition of the label, and the fixation protocol.",
author = "Speer, {K. P.} and Leigh Quarles and Harrelson, {J. M.} and Nunley, {J. A.}",
year = "1991",
language = "English (US)",
pages = "224--227",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
publisher = "Springer New York",
number = "267",

}

TY - JOUR

T1 - Tetracycline labeling of the femoral head following acute intracapsular fracture of the femoral neck

AU - Speer, K. P.

AU - Quarles, Leigh

AU - Harrelson, J. M.

AU - Nunley, J. A.

PY - 1991

Y1 - 1991

N2 - The purpose of this study was to assess the utility of tetracycline hydrochloride (HCl) labeling of the femoral head following acute intracapsular fracture of the femoral neck to indirectly assess femoral head viability and vascularity. A standard labeling (1.5-3.0 g) and fixative protocol (70% ethanol) was used. The initial tetracycline dose was given in the emergency room. The time from last dose to bone sampling in the operating room ranged from six to 36 hours (average, 21.2 hours). There was no evidence of tetracycline deposition at the bone-osteoid interface in any of the femoral head specimens or the ipsilateral extracapsular greater trochanter control specimens. Sources of labeling failure are multifactorial: problems with label delivery to the patient, in vivo deposition of the label, and the fixation protocol.

AB - The purpose of this study was to assess the utility of tetracycline hydrochloride (HCl) labeling of the femoral head following acute intracapsular fracture of the femoral neck to indirectly assess femoral head viability and vascularity. A standard labeling (1.5-3.0 g) and fixative protocol (70% ethanol) was used. The initial tetracycline dose was given in the emergency room. The time from last dose to bone sampling in the operating room ranged from six to 36 hours (average, 21.2 hours). There was no evidence of tetracycline deposition at the bone-osteoid interface in any of the femoral head specimens or the ipsilateral extracapsular greater trochanter control specimens. Sources of labeling failure are multifactorial: problems with label delivery to the patient, in vivo deposition of the label, and the fixation protocol.

UR - http://www.scopus.com/inward/record.url?scp=0026326683&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026326683&partnerID=8YFLogxK

M3 - Article

SP - 224

EP - 227

JO - Clinical Orthopaedics and Related Research

JF - Clinical Orthopaedics and Related Research

SN - 0009-921X

IS - 267

ER -